Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

Positron Emission Tomography in the Diagnosis and Treatment Management of Tuberculosis

(2012) J. G.W. Kosterink   CURRENT PHARMACEUTICAL DESIGN

New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future

(2012) Christian Lienhardt et al.   JOURNAL OF INFECTIOUS DISEASES

Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap

(2011) Payam Nahid et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Models and approaches for anti-TB drug testing

(2011) Yuliya Yasinskaya et al.   Expert Review of Anti-Infective Therapy

Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

(2011) Isobella Honeyborne et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit

(2011) Patrick Royston et al.   Trials

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

(2009) Susan E. Dorman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

SputumMycobacterium tuberculosismRNA as a Marker of Bacteriologic Clearance in Response to Antituberculosis Therapy

(2009) L. Li et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

(2009) Marcus B Conde et al.   LANCET

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

(2009) Matthew R Sydes et al.   Trials

Speeding up the Evaluation of New Agents in Cancer

(2008) M. K. B. Parmar et al.   JNCI-Journal of the National Cancer Institute

Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)

(2008) Andrew J. Nunn et al.   TUBERCULOSIS